Published in Circulation on February 17, 2004
TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77
HMGB1: endogenous danger signaling. Mol Med (2008) 4.02
HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med (2007) 3.72
The immune system and cardiac repair. Pharmacol Res (2008) 3.42
The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol (2014) 1.99
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol (2008) 1.95
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95
Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg (2008) 1.91
Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports (2014) 1.90
Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med (2010) 1.85
Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res (2008) 1.80
Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling. Circ Heart Fail (2011) 1.75
TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol (2008) 1.73
Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience (2008) 1.73
Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol (2012) 1.73
Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injury. Am J Physiol Cell Physiol (2010) 1.69
Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2012) 1.66
The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res (2011) 1.64
Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J Clin Invest (2009) 1.56
Contribution of Toll-like receptor activation to lung damage after donor brain death. Transplantation (2010) 1.47
Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol (2016) 1.46
Molecular mediators of liver ischemia and reperfusion injury: a brief review. Mol Med (2008) 1.43
Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med (2010) 1.41
TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res (2010) 1.40
Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol (2008) 1.35
Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ Res (2009) 1.34
Extracellular matrix roles during cardiac repair. Life Sci (2010) 1.32
Toll-like receptors, wound healing, and carcinogenesis. J Mol Med (Berl) (2008) 1.27
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res (2016) 1.27
Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem (2011) 1.27
CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol (2008) 1.23
Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol (2015) 1.22
Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice. Hepatology (2013) 1.21
Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology (2009) 1.20
Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function. BMC Physiol (2007) 1.19
Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. Am J Physiol Heart Circ Physiol (2009) 1.18
Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation (2009) 1.17
Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol (2009) 1.15
Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia. J Cell Mol Med (2009) 1.13
Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest (2013) 1.10
MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. J Mol Cell Cardiol (2012) 1.09
The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol (2014) 1.08
Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol (2006) 1.08
Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. J Neuroimmunol (2008) 1.08
Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Intensive Care Med (2010) 1.07
Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res (2012) 1.07
Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock. J Immunol (2009) 1.07
TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J Leukoc Biol (2009) 1.06
Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice. Clin Exp Immunol (2014) 1.04
Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid Redox Signal (2011) 1.04
Processes of sterile inflammation. J Immunol (2013) 1.04
Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am J Pathol (2007) 1.03
Toll-like receptors and myocardial inflammation. Int J Inflam (2011) 1.03
Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm (2013) 1.02
Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation. Am J Pathol (2009) 1.02
Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury. J Am Heart Assoc (2014) 1.01
TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway. J Immunol (2012) 1.00
The multiple facets of toll-like receptors in transplantation biology. Transplantation (2008) 0.99
Innate immunity and remodelling. Heart Fail Rev (2011) 0.98
Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia. Oncotarget (2010) 0.98
Toll-like receptor 4 signaling in dysfunction of cardiac microvascular endothelial cells under hypoxia/reoxygenation. Inflamm Res (2010) 0.98
Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways. Am J Physiol Heart Circ Physiol (2010) 0.97
MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovasc Res (2014) 0.96
Toll-like receptors, tissue injury, and tumourigenesis. Mediators Inflamm (2010) 0.96
Selective roles for toll-like receptors 2, 4, and 9 in systemic inflammation and immune dysfunction following peripheral tissue injury. J Trauma Acute Care Surg (2013) 0.95
Human myocardium releases heat shock protein 27 (HSP27) after global ischemia: the proinflammatory effect of extracellular HSP27 through toll-like receptor (TLR)-2 and TLR4. Mol Med (2014) 0.95
Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms. Anesthesiology (2011) 0.94
New insights into insulin: The anti-inflammatory effect and its clinical relevance. World J Diabetes (2014) 0.94
Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol (2015) 0.93
Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction. PLoS One (2013) 0.93
Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation (2008) 0.92
Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases. Cardiovasc Ther (2009) 0.92
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation. Mediators Inflamm (2016) 0.92
Oxidative Stress and Lung Ischemia-Reperfusion Injury. Oxid Med Cell Longev (2015) 0.91
Alloimmune activation enhances innate tissue inflammation/injury in a mouse model of liver ischemia/reperfusion injury. Am J Transplant (2010) 0.91
Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Hum Mol Genet (2014) 0.91
Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor. Front Physiol (2014) 0.90
Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Exp Mol Pathol (2012) 0.90
CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling. Biochim Biophys Acta (2012) 0.90
Mechanical ventilation modulates Toll-like receptor-3-induced lung inflammation via a MyD88-dependent, TLR4-independent pathway: a controlled animal study. BMC Pulm Med (2010) 0.90
Ischemia-reperfusion lung injury is attenuated in MyD88-deficient mice. PLoS One (2013) 0.89
Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury. Biochim Biophys Acta (2013) 0.89
Ischemia/reperfusion injury: The role of immune cells. World J Cardiol (2010) 0.89
Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia. Cardiol Res Pract (2012) 0.89
Therapeutic targeting of innate immunity in the failing heart. J Mol Cell Cardiol (2010) 0.89
Lipopolysaccharides directly decrease Ca2+ oscillations and the hyperpolarization-activated nonselective cation current If in immortalized HL-1 cardiomyocytes. Am J Physiol Cell Physiol (2010) 0.88
Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway. Int J Mol Med (2012) 0.88
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets. Innate Immun (2010) 0.87
Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc (2010) 0.87
Whole blood transcriptomics in cardiac surgery identifies a gene regulatory network connecting ischemia reperfusion with systemic inflammation. PLoS One (2010) 0.87
The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair. Int J Mol Sci (2013) 0.87
It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection. Future Neurol (2009) 0.86
CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. J Am Heart Assoc (2013) 0.86
Cyclic stretch enhances the expression of toll-like receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-kappaB pathway. J Biomed Sci (2010) 0.85
Anti-inflammatory effects of the chinese herbal formula sini tang in myocardial infarction rats. Evid Based Complement Alternat Med (2014) 0.85
Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury. Curr Cardiol Rev (2009) 0.85
Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword. Front Immunol (2014) 0.85
Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury. Evid Based Complement Alternat Med (2013) 0.84
SR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages. Biochim Biophys Acta (2012) 0.84
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Ipr1 gene mediates innate immunity to tuberculosis. Nature (2005) 4.53
Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study. J Infect Dis (2013) 2.47
The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med (2004) 2.46
MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest (2012) 2.24
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci U S A (2008) 2.22
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet (2012) 2.17
Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci (2008) 2.13
Maternal obesity at conception programs obesity in the offspring. Am J Physiol Regul Integr Comp Physiol (2007) 2.08
Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest (2008) 2.04
Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med (2013) 2.01
Pancreatic safety of incretin-based drugs--FDA and EMA assessment. N Engl J Med (2014) 1.95
Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.93
Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol (2005) 1.89
Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol (2003) 1.80
Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells. Circ Res (2002) 1.78
Allergy risk is mediated by dendritic cells with congenital epigenetic changes. Am J Respir Cell Mol Biol (2010) 1.71
Reactive oxygen species in pulmonary inflammation by ambient particulates. Free Radic Biol Med (2003) 1.62
Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J (2003) 1.58
The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am J Respir Cell Mol Biol (2006) 1.57
Pivotal Advance: Expansion of small sputum macrophages in CF: failure to express MARCO and mannose receptors. J Leukoc Biol (2009) 1.56
MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol (2005) 1.53
Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma. Cell Cycle (2013) 1.52
Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Invest (2007) 1.52
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature (2016) 1.52
Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. J Immunol (2005) 1.43
Innate immunity and angiogenesis. Circ Res (2005) 1.42
Rapamycin affects tissue plasminogen activator and plasminogen activator inhibitor I expression: a potential prothrombotic mechanism of drug-eluting stents. Angiology (2011) 1.42
Allergen-independent maternal transmission of asthma susceptibility. J Immunol (2003) 1.42
Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility. Am J Respir Cell Mol Biol (2007) 1.41
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. J Med Chem (2004) 1.37
Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts. Am J Pathol (2009) 1.34
Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J (2007) 1.33
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A (2006) 1.32
Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol (2002) 1.29
Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model. J Mol Med (Berl) (2006) 1.28
Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol (2003) 1.23
Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia. Am J Respir Crit Care Med (2003) 1.23
The role of natural IgM in myocardial ischemia-reperfusion injury. J Mol Cell Cardiol (2006) 1.22
Risk for asthma in offspring of asthmatic mothers versus fathers: a meta-analysis. PLoS One (2010) 1.22
Lung macrophage-epithelial cell interactions amplify particle-mediated cytokine release. Am J Respir Cell Mol Biol (2002) 1.19
Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae. Am J Respir Cell Mol Biol (2006) 1.17
Effect of Diagnostic and Treatment Delay on the Risk of Tuberculosis Transmission in Shenzhen, China: An Observational Cohort Study, 1993-2010. PLoS One (2013) 1.16
Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides. J Leukoc Biol (2006) 1.15
Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A. J Biol Chem (2010) 1.14
Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity. J Immunol (2007) 1.14
Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. J Pharmacol Exp Ther (2006) 1.12
Exposure of pregnant mice to an air pollutant aerosol increases asthma susceptibility in offspring. J Toxicol Environ Health A (2007) 1.11
Physiologic and genomic analyses of nutrition-ethanol interactions during gestation: Implications for fetal ethanol toxicity. Exp Biol Med (Maywood) (2006) 1.11
MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. Am J Respir Cell Mol Biol (2011) 1.11
Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages. J Leukoc Biol (2004) 1.10
Scavenger Receptors SR-AI/II and MARCO limit pulmonary dendritic cell migration and allergic airway inflammation. J Immunol (2007) 1.10
Optical measurement network for large-scale and shell-like objects. Opt Lett (2011) 1.10
Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir Res (2008) 1.10
Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol (2002) 1.10
SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol (2008) 1.10
S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance. Cell Res (2011) 1.09
Air pollution particles diminish bacterial clearance in the primed lungs of mice. Toxicol Appl Pharmacol (2007) 1.08
High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res (2006) 1.08
The class A scavenger receptor, macrophage receptor with collagenous structure, is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages. J Immunol (2010) 1.08
Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils. Stem Cells (2013) 1.08
Methanosaeta harundinacea sp. nov., a novel acetate-scavenging methanogen isolated from a UASB reactor. Int J Syst Evol Microbiol (2006) 1.06
Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells. Circulation (2008) 1.05
Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro. Nanotoxicology (2014) 1.03
Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis. J Immunol (2011) 1.03
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters. J Pharmacol Exp Ther (2004) 1.03
Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice. Antioxid Redox Signal (2012) 1.02
Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis. Trends Cardiovasc Med (2002) 1.01
Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury. Circ Res (2005) 1.01
Syntrophomonas curvata sp. nov., an anaerobe that degrades fatty acids in co-culture with methanogens. Int J Syst Evol Microbiol (2004) 1.01
Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance. Int J Cancer (2010) 1.01
Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol (2004) 0.99
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth. Oncotarget (2013) 0.99
TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi. Infect Immun (2012) 0.99
In vitro modeling of human alveolar macrophage smoke exposure: enhanced inflammation and impaired function. Exp Lung Res (2008) 0.98
Role of breast milk in a mouse model of maternal transmission of asthma susceptibility. J Immunol (2006) 0.98
Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer. J Clin Endocrinol Metab (2015) 0.98
Maternal allergic contact dermatitis causes increased asthma risk in offspring. Respir Res (2007) 0.97
Maternal transmission of asthma risk. Am J Reprod Immunol (2008) 0.97
Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor. J Med Chem (2013) 0.97
Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials (2012) 0.96
Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol (2013) 0.96
Divergent cardiopulmonary actions of heme oxygenase enzymatic products in chronic hypoxia. PLoS One (2009) 0.96
Acyl homoserine lactone-based quorum sensing in a methanogenic archaeon. ISME J (2012) 0.96
Alkaliphilus crotonatoxidans sp. nov., a strictly anaerobic, crotonate-dismutating bacterium isolated from a methanogenic environment. Int J Syst Evol Microbiol (2003) 0.95
Immunostimulatory CpG oligonucleotides abrogate allergic susceptibility in a murine model of maternal asthma transmission. J Immunol (2005) 0.95
Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1). Endocrinology (2007) 0.95
Double acoustic microresonator quartz-enhanced photoacoustic spectroscopy. Opt Lett (2014) 0.95
Chinese Culture, Homosexuality Stigma, Social Support and Condom Use: A Path Analytic Model. Stigma Res Action (2011) 0.95
A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res (2007) 0.94
Scavenger receptors and β-glucan receptors participate in the recognition of yeasts by murine macrophages. Inflamm Res (2011) 0.94
Nitric oxide synthase-2 down-regulates surfactant protein-B expression and enhances endotoxin-induced lung injury in mice. FASEB J (2004) 0.94
Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics (2002) 0.94
Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One (2013) 0.93
Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness. J Appl Physiol (1985) (2004) 0.93
Standardizing scavenger receptor nomenclature. J Immunol (2014) 0.93
Short term effects on bone quality associated with consumption of soy protein isolate and other dietary protein sources in rapidly growing female rats. Exp Biol Med (Maywood) (2008) 0.93
Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease. Arch Ophthalmol (2010) 0.93
A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients. PLoS One (2013) 0.93